Expanded Program
Plenary Sessions
September 25th
- The Business of Stem Cells and Existing Models
Moderator: Michael J. Werner, Esq.,
President, The Werner Group
Panel: Gabriela Cezar, Assistant Professor, University of Wisconsin - Madison; Elizabeth Donley, Chief Executive Officer, Stemina; Michael Haider, President and CEO, BioE, Inc. - GE Healthcare’s Vision
Speaker: Michael J. Barber, Vice President
and Chief Technology Officer, GE Healthcare
September 26th
- Changes and Trends in Third Party Payer Policy
Moderator: Deron Curliss, Partner, Grant Thornton LLP
Panel: Robert Beckman, President & CEO, Wicab; John Foley, Vice President, Health Services, Anthem Blue Cross and Blue Shield; Irene Hrusovsky, President and CEO, Eragen Biosciences; Jayson Slotnik, Associate, Hogan and Hartson LLP
Workshops
September 25th
- Healthcare and Venture Capital in the Midwest
Moderator: Peter Shagory, Partner, Baird Venture Partners
Panel: George Emont, Venture Partner, Triathlon Medical Ventures; Michael Liang, Vice President, Baird Venture Partners; John Neis, Co-Founder and Managing Director, Venture Investors LLC; James A, Scozzie, Senior Vice President, BioEnterprise - FDA: What’s Coming Up Next?
Moderator: Daniel J. Broderick, Venture Partner, Prolog Ventures
Panel: Andrew Emmett, Director, Science and Regulatory Affairs, BIO; Steve Irizarry, Vice President, Government Relations, ML Strategies, LLC; Kelly Slone, Director, Medical Industry Group, National Venture Capital Association - Bioenergy: Investment, Trends, and Development Opportunities in the Renewable Energy Sector
Moderator: Gregory J. Lynch, Partner, Michael Best & Friedrich LLP
Panel: John Biondi, President, C5-6 Technologies, Inc; James R. Hattenhaus, Co-Founder, CEA Inc.; David Miles, CEO, Countryside Energy - Cooperative Financing
Moderator: Mark T Ehrmann, Partner and Chair, Private Equity/Venture Capital Group, Quarles & Brady LLP
Panel: Tony Deahl, Divisional Vice President, Global Licensing & Business Development, Abbott; Steve Einhorn, President, Einhorn Associates, Inc.; George E. Mosher, Angel Investor; Kathy Tune, Associate, Thomas, McNerney & Partners;
September 26th
- Collaborative Opportunities
Moderator: Grady Frenchick, Attorney, Whyte Hirschboeck Dudek S.C.
Panel: Allen Dines, Assistant Director, Office of Corporate Relations, University of Wisconsin - Madison; Craig Christianson, Director of Licensing, Wisconsin Alumni Research Foundation; Susan Z. Paquette, Commercialization Director, 3M Health Care Business; - Convergence
Moderator: Richard Meyer, Partner, Townsend and Townsend and Crew LLP
Panel: Douglas Astry, General Manager, In Vitro Technologies, Surmodics; Richard Klein, President and Co-Founder, Medlogics Device Corporation; Peter Kleinhenz, Managing Director, CID Capital